Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
6,652,555
-
Share change
-
+443,966
-
Total reported value
-
$218,869,000
-
Price per share
-
$32.90
-
Number of holders
-
56
-
Value change
-
+$15,470,941
-
Number of buys
-
35
-
Number of sells
-
21
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2019
As of 31 Mar 2019,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,652,555 shares.
The largest 10 holders included
FMR LLC, FRAZIER MANAGEMENT LLC, BAKER BROS. ADVISORS LP, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, Redmile Group, LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Artal Group S.A., and Knoll Capital Management, LP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.